Crystallographic characterization of the first reported crystalline form of the potent hallucinogen (R)-2-amino-1-(8-bromobenzo[1,2-b;5,4-b']difuran-4-yl)propane or 'bromodragonfly': the 1:1 anhydrous proton-transfer compound with 3,5-dinitrosalicylic acid.

@article{Smith2010CrystallographicCO,
  title={Crystallographic characterization of the first reported crystalline form of the potent hallucinogen (R)-2-amino-1-(8-bromobenzo[1,2-b;5,4-b']difuran-4-yl)propane or 'bromodragonfly': the 1:1 anhydrous proton-transfer compound with 3,5-dinitrosalicylic acid.},
  author={Graham M. Smith and Marcus S Cotton and Urs D. Wermuth and Sue E. Boyd},
  journal={Acta crystallographica. Section C, Crystal structure communications},
  year={2010},
  volume={66 Pt 5},
  pages={o252-5}
}
The 1:1 proton-transfer compound of the potent substituted amphetamine hallucinogen (R)-2-amino-1-(8-bromobenzo[1,2-b;5,4-b']difuran-4-yl)propane (common trivial name 'bromodragonfly') with 3,5-dinitrosalicylic acid, namely 1-(8-bromobenzo[1,2-b;5,4-b']difuran-4-yl)propan-2-aminium 2-carboxy-4,6-dinitrophenolate, C(13)H(13)BrNO(2)(+).C(7)H(3)N(2)O(7… CONTINUE READING